MedTrace Logo

The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis

NCT03383471 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2018-03-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of intraarticular Invossa K Injection patients diagnosed with Kellgren \& Lawrence grade 2 knee osteoarthritis.

Conditions

Interventions

BIOLOGICAL

Invossa K Inj.

Invossa K Inj.

DRUG

Placebo

Placebo control

Sponsors & Collaborators

  • Kolon Life Science

    lead INDUSTRY

Principal Investigators

  • Myung-Chul Lee, MD, PhD · Department of Orthopedic Surgery, Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2019-12-31
Completion
2020-03-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383471 on ClinicalTrials.gov